Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.01M Buy
21,320
+5,600
+36% +$2.01M 0.4% 44
2025
Q4
$5.53M Hold
15,720
0.32% 54
2025
Q3
$5.81M Sell
15,720
-4,930
-24% -$1.9M 0.4% 51
2025
Q2
$8.17M Hold
20,650
0.62% 44
2025
Q1
$7.69M Sell
20,650
-700
-3% -$266K 0.64% 44
2024
Q4
$7.69M Sell
21,350
-3,050
-13% -$1.13M 0.6% 46
2024
Q3
$8.81M Sell
24,400
-2,500
-9% -$863K 0.76% 44
2024
Q2
$9.15M Buy
+26,900
New +$9.11M 0.78% 41

Other funds holding SYK

DNCA Finance's SYK Position: Q1 2026 in Review

DNCA Finance increased its Stryker (SYK) stake by 36% in Q1 2026, buying an estimated $2.01M and bringing the position to 21,320 shares worth $7.01M. The position accounts for 0.4% of the portfolio, ranked #44.

DNCA Finance first reported a position in SYK in Q2 2024 and has held it in 8 quarters since. The position peaked at $9.15M in Q2 2024. 2,294 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • DNCA Finance held 21,320 shares of Stryker worth $7.01M as of Q1 2026.
  • DNCA Finance bought 5,600 Stryker shares in Q1 2026, an estimated $2.01M.
  • Stryker made up 0.4% of DNCA Finance's portfolio in Q1 2026, its #44 holding.
  • DNCA Finance first reported a position in Stryker in Q2 2024 and has held it in 8 quarters since.
  • DNCA Finance's Stryker position peaked at $9.15M in Q2 2024.
  • 2,294 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on DNCA Finance's 13F filing for Q1 2026, filed 14 May 2026.